OBIZUR
OBIZUR
Approved
DIN Number
02447401
Drug Class
Human
Market Date
Nov 30, 2016
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02447401
AIG Number0157496001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANTIHEMOPHILIC FACTOR (RECOMBINANT) PORCINE SEQUENCEActive
Strength: 500 UNIT / ML
Monograph: ANTIHEMOPHILIC FACTOR (RECOMBINANT) PORCINE SEQUENCE